Cytokinetics (CYTK) Leases (2020 - 2025)
Cytokinetics (CYTK) has disclosed Leases for 6 consecutive years, with $76.0 million as the latest value for Q4 2025.
- Quarterly Leases changed N/A to $76.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $76.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $76.0 million for FY2025, N/A changed from the prior year.
- Leases for Q4 2025 was $76.0 million at Cytokinetics, down from $77.6 million in the prior quarter.
- The five-year high for Leases was $83.0 million in Q2 2021, with the low at $72.2 million in Q2 2022.
- Average Leases over 5 years is $77.8 million, with a median of $77.6 million recorded in 2025.
- The sharpest move saw Leases surged 2401.3% in 2021, then decreased 13.07% in 2022.
- Over 5 years, Leases stood at $73.1 million in 2021, then increased by 13.12% to $82.7 million in 2022, then fell by 4.53% to $79.0 million in 2023, then fell by 3.35% to $76.3 million in 2024, then decreased by 0.48% to $76.0 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $76.0 million, $77.6 million, and $76.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.